US 10300073
Use of CDK9 and BRD4 inhibitors to inhibit inflammation
granted A61KA61K31/00A61K31/352
Quick answer
US patent 10300073 (Use of CDK9 and BRD4 inhibitors to inhibit inflammation) held by The Regents of the University of California expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/00, A61K31/352, A61K31/445, A61K31/453